The Current Status of Latency Reversing Agents for HIV-1 Remission.

HIV-1 latency combinatory treatments latency reversing agents shock and kill strategy viral reservoirs

Journal

Annual review of virology
ISSN: 2327-0578
Titre abrégé: Annu Rev Virol
Pays: United States
ID NLM: 101625721

Informations de publication

Date de publication:
29 09 2021
Historique:
entrez: 29 9 2021
pubmed: 30 9 2021
medline: 5 3 2022
Statut: ppublish

Résumé

Combinatory antiretroviral therapy (cART) reduces human immunodeficiency virus type 1 (HIV-1) replication but is not curative because cART interruption almost invariably leads to a rapid rebound of viremia due to the persistence of stable HIV-1-infected cellular reservoirs. These reservoirs are mainly composed of CD4

Identifiants

pubmed: 34586875
doi: 10.1146/annurev-virology-091919-103029
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

491-514

Auteurs

Anthony Rodari (A)

Service of Molecular Virology, Department of Molecular Biology, Université Libre de Bruxelles (ULB), 6041 Gosselies, Belgium; email: Carine.Vanlint@ulb.be.

Gilles Darcis (G)

Infectious Diseases Department, Liège University Hospital, 4000 Liège, Belgium.

Carine M Van Lint (CM)

Service of Molecular Virology, Department of Molecular Biology, Université Libre de Bruxelles (ULB), 6041 Gosselies, Belgium; email: Carine.Vanlint@ulb.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH